astrazeneca oral glp 1 AstraZeneca's GLP-1 scored phase 2 wins, but no data yet AstraZeneca Eyes India Launch for
Description
The effects of glucose levels on the secretion of insulin and glucagon can be managed by glucagon-like peptide-1 (GLP-1) analogs
A Crowded Pipeline Means Strategic Differentiation Is Critical With over 100 assets in clinical development, ranging from multi-agonists like retatrutide (with potential for ~25% weight loss) to oral small molecules like orforglipron , the battle for clinical and commercial leadership will be intense [3]
Experiencing a bad taste in your mouth whilst taking GLP-1 medications is an uncommon but recognised side effect that can affect some patients during treatment
What if I've tried everything else and nothing's worked
ProFound Therapeutics ProFound Therapeutics is leveraging previously undiscovered human proteins to develop treatments for a wide range of diseases
